Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2011
The article by Paek et al provides an opportunity to close professional practice gaps regarding management with long-term dapsone therapy and dietary gluten restrictions in patients with well-controlled dermatitis herpetiformis (DH). The data show that tapering off dapsone doses results in no flaring of disease in significant numbers of patients with DH, so clinicians who were taught to practice otherwise now have evidence-based data to support a closure in their professional practice gap. The data also support modifying a specific component of clinical counseling to close another professional practice gap: few dermatologists were taught that the benefit of a gluten-free diet may change over time, thus altering patient counseling with respect to clinical care.
Mostow EN. Discontinuing Dapsone Treatment and Reintroducing Dietary Gluten in Patients With Dermatitis Herpetiformis in RemissionComment on “Remission in Dermatitis Herpetiformis”. Arch Dermatol. 2011;147(3):305-306. doi:10.1001/archdermatol.2011.33